An international survey of cancer pain characteristics and syndromes

Pain

Volumn 82, Issue 3, 1999, Pages 263-274

  Caraceni, Augusto ^a   Portenoy, Russell K ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Cancer pain classification; Cancer pain syndromes

Indexed keywords

OPIATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PAIN; CANCER THERAPY; CLINICAL TRIAL; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PERFORMANCE; PRIORITY JOURNAL; QUESTIONNAIRE;

CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NEOPLASMS; PAIN MEASUREMENT; QUESTIONNAIRES; SYNDROME;

EID: 0032813617     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00073-1     Document Type: Article

References (42)

1. Agresti A. Categorical data analysis. 1990;Wiley and Sons, New York.
2. Arner S., Arner B. Differential effect of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand. 29:1985;32-36.
3. Asbury A.K., Fields H.L. Pain due to peripheral nerve damage: an hypothesis. Neurology. 34:1984;1587-1590.
4. Ashby M.A., Fleming B.G., Brooksbank M., Rounsefell B., Runciman W.B., Jackson K., Muirden N., Smith M. Description of a mechanistic approach to pain management in advanced cancer. Preliminary report. Pain. 51:1992;153-161.
5. Banning A., Sjogren P., Henriksen H. Treatment outcome in a multidisciplinary cancer pain clinic. Pain. 47:1991;129-134.
6. Brose W.G., Cousins M.J. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain. 45:1991;145-148.
7. Bruera E., MacMillan K., Hanson J., MacDonald R.N. The Edmonton staging system for cancer pain: preliminary report. Pain. 37:1989;203-209.
8. Bruera E., Schoeller T., Wenk R., MacEachern T., Marcellino S., Hanson J., Suarez-Almazor M. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manag. 10:1995;348-355.
9. Caraceni A. Clinicopathological correlates of common cancer pain syndromes. Hematol Oncol Clin North Am. 10:1996;57-78.
10. Caraceni A., Portenoy R.K. Pain management in pancreatic cancer. Cancer. 78:1996;639-653.
11. Cheng T.M., Cascino T.L., Onofrio B.M. Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology. 43:1993;2298-2302.
12. Cherny N.I., Portenoy R.K. Cancer pain: principles of assessment and syndromes. Wall P.D., Melzack R. Textbook of pain. 3rd ed., 1994;787.
13. Cherny N.I., Thaler H.T., Friedlander-Klar H., Lapin J., Foley K.M., Houde R., Portenoy R.K. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology. 44:1994;857-861.
14. Cleeland C.S. The impact of pain on the patient with cancer. Cancer. 54:1984;2635-2641.
15. Cleeland C.S., Ladinsky J.L., Serlin R.C., Nugyen C.T. Multidimensional measurement of cancer pain: comparisons of US and Vietnamese patients. J Pain Symptom Manag. 3:1988;23-27.
16. Cleeland C.S., Gonin R., Hatfield A.K., Edmonson J.H., Blum R.H., Stewart J.A., Pandya K.J. Pain and its treatment in outpatients with metastatic cancer. N Eng J Med. 330:1994;592-596.
17. Daut R.L., Cleeland C.S., Flanery R.C. Development of the wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain. 17:1983;197-210.
18. Daut R.L., Cleeland C.S. The prevalence and severity of pain in cancer. Cancer. 50:1982;1913-1918.
19. De Conno F., Caraceni A., Groff L., Brunelli C., Donati I., Tamburini M., Ventafridda V. Effect of home care on the place of death of advanced cancer patients. Eur J Cancer. 32A:1996;1142-1147.
20. Foley K.M. Pain syndromes in patients with cancer. Bonica J.J., Ventafridda V. Advances in pain research and therapy. vol. 2:1979;59 Raven Press, New York.
21. Gonzales G.R., Elliot K.J., Portenoy R.K., Foley K.M. The impact of a comprehensive evaluation in the management of cancer pain. Pain. 47:1991;141-144.
22. Greenberg H.S., Deck M.D.F., Vikram B., et al. Metastasis to the base of the skull: clinical findings in 43 patients. Neurology. 31:1981;530-537.
23. Grond S., Zech D., Diefenbach C., Radbruch L., Lehman K.A. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 64:1996;107-114.
24. Jaeckle K.A., Young D.F., Foley K.M. The natural history of lumbosacral plexopathy in cancer. Neurology. 35:1985;8-15.
25. Jensen M.P., McFarland C.A. Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain. 55:1993;195-203.
26. Kaiko R.F., Wallenstein S.L., Rogers A.G., Houde R.W. Sources of variation in analgesic responses in cancer patients with chronic pain receiving morphine. Pain. 15:1983;191-200.
27. Kori S.H., Foley K.M., Posner J.B., et al. Brachial plexus lesions in patients with cancer 100 cases. Neurology. 31:1981;45-50.
28. Mercadante S., Maddaloni S., Roccella S., Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain. 50:1992;151-155.
29. Mercadante S., Armata M., Salvaggio L. Pain characteristics of advanced lung cancer patients referred to a palliative care service. Pain. 59:1994;141-145.
30. Portenoy R.K. Cancer pain: pathophysiology and syndromes. Lancet. 339:1992;1026-1031.
31. Portenoy R.K., Hagen N.A. Breakthrough pain: definition, prevalence and characteristics. Pain. 41:1990;273-281.
32. Portenoy R.K., Miransky J., Thaler H.T., Hornung J., Bianchi C., Cibas-Kong I., Feldhamer E., Lewis F., Matamoros I., Sugar M.Z., Olivieri A.P., Kemeny N.E., Foley K.M. Pain in ambulatory patients with lung and colon cancer. Prevalence, characteristics and effect. Cancer. 70:1992;1616-1624.
33. Portenoy R.K., Komblith A.B., Wong G., Vlamis V., McCarthy Lepore J., Loseth D.B., Hakes T., Foley K.M., Hoskins W.J. Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer. 74:1994;907-915.
34. Serlin R.C., Mendoza T.R., Nakamura Y., Edwards K.R., Cleeland C.S. When is cancer pain mild moderate or severe? Grading pain severity by its interference with function. Pain. 61:1995;277-284.
35. Twycross R.G., Fairfield S. Pain in far-advanced cancer. Pain. 14:1982;303-310.
36. Twycross R., Harcourt J., Bergl S. A survey of pain in patients with advanced cancer. J Pain Symptom Manag. 12:1996;273-282.
37. Vecht C.J. Arm pain in the patient with breast cancer. J Pain Symptom Manag. 5:1990;109-117.
38. Vecht C.J., Van de Brand H.J., Wajer O.J. Post-axillary dissection pain in breast cancer due to a lesion of the intercostobrachial nerve. Pain. 38:1989;171-176.
39. Vecht C.J., Hoff A.M., Kansen P.J., de Boer M., Bosch D.A. Types and causes of pain in cancer of the head and neck. Cancer. 70:1992;178-184.
40. Ventafridda V., Caraceni A. Cancer pain classification: a controversial issue. Pain. 46:1991;1-2.
41. Vigano A., Fan D., Bruera E. Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain. 67:1996;115-119.
42. Yates J.W., Chalmer B., McKegney F.P. Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer. 45:1980;2220-2224.